251 related articles for article (PubMed ID: 24560113)
1. Transarterial therapies for primary liver tumors.
Talenfeld AD; Sista AK; Madoff DC
Surg Oncol Clin N Am; 2014 Apr; 23(2):323-51. PubMed ID: 24560113
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
Tsochatzis EA; Germani G; Burroughs AK
Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization and radioembolization.
Sangro B; Salem R
Semin Liver Dis; 2014 Nov; 34(4):435-43. PubMed ID: 25369305
[TBL] [Abstract][Full Text] [Related]
4. Transarterial approaches to primary and secondary hepatic malignancies.
Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
Nat Rev Clin Oncol; 2015 Aug; 12(8):481-9. PubMed ID: 25985939
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
6. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
Tsochatzis E; Meyer T; Marelli L; Burroughs AK
J Hepatol; 2010 Sep; 53(3):588. PubMed ID: 20472319
[No Abstract] [Full Text] [Related]
7. Transarterial therapies for hepatocellular carcinoma.
Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Miura JT; Gamblin TC
Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization and bland embolization for hepatocellular carcinoma.
Tsochatzis EA; Fatourou E; O'Beirne J; Meyer T; Burroughs AK
World J Gastroenterol; 2014 Mar; 20(12):3069-77. PubMed ID: 24695579
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
[TBL] [Abstract][Full Text] [Related]
12. New concepts in embolotherapy of HCC.
Pesapane F; Nezami N; Patella F; Geschwind JF
Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
[TBL] [Abstract][Full Text] [Related]
13. Transarterial therapies for hepatocellular carcinoma.
Tsochatzis EA; Fatourou EM; Triantos CK; Burroughs AK
Recent Results Cancer Res; 2013; 190():195-206. PubMed ID: 22941022
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
Liapi E; Geschwind JF
Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization and radioembolization.
Sangro B
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):909-19. PubMed ID: 25260317
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies.
Lopez RR; Pan SH; Lois JF; McMonigle ME; Hoffman AL; Sher LS; Lugo D; Makowka L
Am Surg; 1997 Oct; 63(10):923-6. PubMed ID: 9322674
[TBL] [Abstract][Full Text] [Related]
17. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
19. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.
Vogl TJ; Naguib NN; Nour-Eldin NE; Rao P; Emami AH; Zangos S; Nabil M; Abdelkader A
Eur J Radiol; 2009 Dec; 72(3):505-16. PubMed ID: 18835117
[TBL] [Abstract][Full Text] [Related]
20. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
